
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sulf-2 CRISPR/Cas9 KO Plasmid (h) | sc-403277 | 20 µg | $397.00 |
SULF2 encodes Sulf-2, an extracellular endosulfatase that selectively removes 6-O-sulfate groups from heparan sulfate proteoglycans, thereby reshaping the sulfation code that controls ligand availability and receptor engagement. By editing heparan sulfate at the cell surface and in the pericellular matrix, Sulf-2 modulates signaling outputs from pathways such as FGF, WNT, and VEGF, influencing cell proliferation, migration, differentiation, and adhesion. Altered SULF2 expression and heparan sulfate remodeling have been associated with tumor microenvironment regulation, invasive behavior, and angiogenic responses, and are also relevant to fibrotic and inflammatory processes. These functions make SULF2 a useful target for dissecting extracellular matrix–dependent signaling and glycosaminoglycan-mediated regulation of cell communication.
Sulf-2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SULF2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SULF2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SULF2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sulf-2 protein expression.
This CRISPR knockout system enables efficient generation of SULF2-deficient cell models for investigation of Sulf-2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.